This new data is in agreement with a recent report about u-Gal-3BP, where urinary levels of this marker were found to be higher cross-sectionally in LN patients compared to healthy controls and CKD patients.26 Importantly, our study included active non-renal SLE as a comparator. This evidence concerns the gene GAL and systemic lupus erythematosus.